Cardiac sodium-glucose co-transporter 1 (SGLT1) contributes to heart failure in a mouse model of diabetic cardiomyopathy

By afschroeder • September 12, 2025

Li Z, Freiberg S, Music ML, Gu L, Nacos S, Phillips JP, Hassan A, Shibbani K, Munir SS, Kumar VK, Halligan L, Michel ME, London BF, Bui N, Cicha M, Buffard V, Abel ED, Ahmad F. Cardiac sodium-glucose co-transporter 1 (SGLT1) contributes to heart failure in a mouse model of diabetic cardiomyopathy. Basic Res Cardiol. 2025 Sep 11. doi: 10.1007/s00395-025-01136-7. Epub ahead of print. PMID: 40932483.

Tags: cardiomyopathy, diabetes, Endocrinology, fibrosis, glucose, Insulin, Oxidative stress, Publications

Regular Insulin Versus NPH Insulin for Continuous Enteral Tube Feeding in Hospitalized Patients

Kalangi ST, Bokka SM, Anand S, Garg R. Regular Insulin Versus NPH Insulin for Continuous Enteral Tube Feeding in Hospitalized Patients. Clin Diabetes. 2025 Apr[...]

Real-World Interventions for Type 2 Diabetes Prevention (REALITY): A Multisite Study to Assess the Effectiveness and Cost-Effectiveness of the National Diabetes Prevention Program

Herman WH, Tyndall BD, Duru OK, Moin T, McEwen LN, Shao H, Ackermann RT, Jacobs SR, Neuwahl S, Kuo S, Zhang P, Pavkov ME, Villatoro[...]

Nardilysin in adipocyte regulates insulin sensitivity via HIF1alpha and PPARgamma

Matsuda S, Ohno M, Nishi K, Ikeda S, Iwasaki H, Eifuku T, Hiraoka Y, Kimura T, Ono K, Nishi E. Nardilysin in adipocyte regulates insulin[...]